Drug Profile
Carbinoxamine extended-release - Tris Pharma
Alternative Names: Carbinoxamine maleate extended-release - Tris Pharma; Karbinal ERLatest Information Update: 24 Mar 2021
Price :
$50
*
At a glance
- Originator Tris Pharma
- Class Antiallergics; Antihistamines; Chlorobenzenes; Dimethylamines; Ethanolamines; Pyridines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Perennial allergic rhinitis; Seasonal allergic rhinitis